Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Lux Biosciences, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Active noninfectious uveitis involving the intermediate and/or posterior segment (i.e., anterior + intermediate-, intermediate-, posterior- or pan-uveitis) in at least one eye as evidenced by a vitreous haze grade of at least 2+ at the baseline visit. Subjects who also have anterior segment involvement need not be excluded if otherwise qualified.
Subjects must be:
* Capable of understanding the purpose and risks of the study.
* Able to give written informed consent.
* Able to comply with all study requirements.
You may not be if
Ocular Disease/Conditions
The following conditions are exclusionary if present:
* Uveitis limited to only the anterior segment of the study eye.
* Confirmed or suspected infectious uveitis in either eye.
Prior and Current Treatment:
\- As defined in the protocol
Extraocular Conditions:
\- As defined in the protocol.
Laboratory, Blood Pressure and ECG Evaluations:
* As defined in the protocol.
Clareo Health | Efficacy and Safety of Voclosporin to Treat Active Noninfectious Uveitis
